{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:39:45Z","timestamp":1778629185905,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.jvir.2008.11.019","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T09:58:15Z","timestamp":1232791095000},"page":"360-367","source":"Crossref","is-referenced-by-count":68,"title":["Salvage Therapy for Liver-dominant Colorectal Metastatic Adenocarcinoma: Comparison between Transcatheter Arterial Chemoembolization versus Yttrium-90 Radioembolization"],"prefix":"10.1016","volume":"20","author":[{"given":"Kelvin","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy D.","family":"McBride","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos S.","family":"Georgiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane K.","family":"Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab R.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Fran\u00e7ois H.","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2008.11.019_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/canjclin.55.1.10","article-title":"Cancer statistics, 2005","volume":"55","author":"Jemal","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jvir.2008.11.019_bib2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711500308","article-title":"Haematogenous metastasis patterns in colonic carcinoma: an analysis of 1541 necropsies","volume":"150","author":"Weiss","year":"1986","journal-title":"J Pathol"},{"key":"10.1016\/j.jvir.2008.11.019_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1250::AID-CNCR7>3.0.CO;2-J","article-title":"Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature","volume":"82","author":"Tellez","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2008.11.019_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.suronc.2007.04.008","article-title":"Epidemiology of colorectal liver metastases","volume":"16","author":"McMillan","year":"2007","journal-title":"Surg Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib5","first-page":"448","article-title":"The role of chemoembolization in the treatment of colorectal hepatic metastasis","volume":"48","author":"Patel","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jvir.2008.11.019_bib6","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1097\/01.RVI.0000179815.44868.66","article-title":"90Y microsphere (Therasphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135\u2013150 Gy as measured by (18F) Fluorodeoxyglucose positron emission tomography and computed tomographic imaging","volume":"16","author":"Lewandowski","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib7","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM200009283431302","article-title":"Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer","volume":"343","author":"Saltz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvir.2008.11.019_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/JCO.2004.09.046","article-title":"Randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer","volume":"22","author":"Goldberg","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib9","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.1993.11.5.909","article-title":"Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer","volume":"11","author":"Shimada","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1200\/JCO.2004.05.113","article-title":"FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study","volume":"22","author":"Tournigand","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib11","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","article-title":"Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial","volume":"359","author":"Llovet","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jvir.2008.11.019_bib12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","article-title":"Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma","volume":"35","author":"Lo","year":"2002","journal-title":"Hepatology"},{"issue":"suppl","key":"10.1016\/j.jvir.2008.11.019_bib13","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1016\/S1051-0443(07)61790-4","article-title":"Yttrium-90 microspheres: radiation therapy for unresectable liver cancer","volume":"13","author":"Salem","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib14","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1051-0443(07)61769-2","article-title":"Quality improvement guidelines for the reporting and archiving of interventional radiology procedures","volume":"13","author":"Omary","year":"2002","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib15","first-page":"1673","article-title":"Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres","volume":"41","author":"Dancey","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2008.11.019_bib16","first-page":"1637","article-title":"Hepatic radioembolization with Yttrium-90 containing glass microspheres: preliminary results and clinical follow-up","volume":"35","author":"Andrews","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2008.11.019_bib17","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.RVI.0000161142.12822.66","article-title":"Yttrium 90 resin microspheres for the treatment of unresectable colorectal hepatic metastases after failure of multiple chemotherapy regimens: preliminary results","volume":"16","author":"Murthy","year":"2005","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib18","unstructured":"Yu M, Lewandowski RJ, Wong CO, et al. Yttrium-90 (SIR-Spheres\u00ae) treatment for metastatic cancer to the liver: midterm results. Presented at the 31st Annual Meeting of the Society of Interventional Radiology; March 31, 2006; Toronto, Canada. Abstract SS03 no. 17; S8."},{"key":"10.1016\/j.jvir.2008.11.019_bib19","unstructured":"Atassi B, Lewandowski RJ, Mulachy M, et al. Treatment with yttrium-90 microspheres of unresectable metastatic colorectal cancer to the liver: safety, treatment response and survival. Presented at the American Society of Clinical Oncology Gastrointestinal Malignancies Symposium; January 26\u201328, 2006; San Francisco, CA."},{"key":"10.1016\/j.jvir.2008.11.019_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/01.RVI.0000235779.88652.53","article-title":"Radioembolization with 90 yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib22","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1097\/01.RVI.0000236744.34720.73","article-title":"Radioembolization with yttrium-90 microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 3: comprehensive literature review and future direction","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/028418518602700203","article-title":"Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in ionized oil suspension or of radioactive iodized oil solution","volume":"27","author":"Kaboyashi","year":"1986","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1148\/radiol.2241011262","article-title":"Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized trials","volume":"224","author":"Camma","year":"2002","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2008.11.019_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/01.RVI.0000196277.76812.A3","article-title":"Society of Interventional Radiology position statement on chemoembolization of hepatic malignancies","volume":"17","author":"Brown","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib26","first-page":"190","article-title":"Chemoembolization for colorectal metastases","volume":"14","author":"Stuart","year":"1995","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib27","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1148\/radiology.189.2.8210369","article-title":"Colorectal metastases to the liver: selective chemoembolization","volume":"189","author":"Lang","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2008.11.019_bib28","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1007\/BF02055430","article-title":"Selective chemoembolization in the management of hepatic metastases in refractory colorectal carcinoma: a phase II trial","volume":"40","author":"Sanz-Altamira","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jvir.2008.11.019_bib29","first-page":"305","article-title":"Chemoembolization of hepatic malignancies","volume":"14","author":"Soulen","year":"1997","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib30","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000055226","article-title":"A new chemoembolization protocol in refractory liver metastases of colorectal cancer \u2013 a feasibility study","volume":"25","author":"Voigt","year":"2002","journal-title":"Onkologie"},{"key":"10.1016\/j.jvir.2008.11.019_bib31","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/02841868709089978","article-title":"Intraarterial mitomycin c treatment of unresectable liver tumors: preliminary results on the effect of degradable starch microspheres","volume":"26","author":"Starkhammar","year":"1987","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib32","doi-asserted-by":"crossref","first-page":"5222","DOI":"10.1007\/s00270-005-0171-4","article-title":"Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere): assessment of hepatic arterial embolization","volume":"29","author":"Sato","year":"2006","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00270-002-2524-6","article-title":"Transcatheter arterial chemoembolization of liver tumors: effects of embolization protocol on injectable volume of chemotherapy and subsequent arterial patency","volume":"26","author":"Geschwind","year":"2003","journal-title":"Cardiovasc Inervent Radiol"},{"key":"10.1016\/j.jvir.2008.11.019_bib34","first-page":"49","article-title":"Comparison of post-embolization syndrome in the treatment of patients with unresectable hepatocellular carcinoma: trans-catheter arterial chemoembolization versus yttrium-90 glass microspheres","volume":"3","author":"Goin","year":"2004","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.jvir.2008.11.019_bib35","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jso.20141","article-title":"Randomized phase 2 trial of SIR-Spheres plus fluorouracil\/leucovorin chemotherapy versus fluorouracil\/leucovorin chemotherapy alone in advanced colorectal cancer","volume":"88","author":"Van Hazel","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jvir.2008.11.019_bib36","first-page":"3793","article-title":"Transarterial chemoembolization (TACE) of liver metastases from colorectal from colorectal cancer using irinotecan-eluting beads","volume":"26","author":"Aliberti","year":"2006","journal-title":"Anticancer Res"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044308010865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044308010865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T14:24:45Z","timestamp":1558103085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044308010865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1051044308010865"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2008.11.019","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}